Abstract
This study investigates the benefits of minimal residual disease in a subset of AML patients with inv(16) by means of non-quantitative detection of CBFβ/MYH11 fusion transcript. We found that CBFβ/MYH11 RT-PCR negativity is associated with cure of disease.
Original language | English |
---|---|
Pages (from-to) | 552-554 |
Number of pages | 3 |
Journal | Haematologica |
Volume | 85 |
Issue number | 5 |
Publication status | Published - May 2000 |
ASJC Scopus subject areas
- Hematology